PBAC comment opportunity by MAY 20 for VUTRISIRAN proposal to treat ATTR-CM
The next meeting of the PBAC will be in July 2026. At this meeting committee will be considering a request from [...]
The next meeting of the PBAC will be in July 2026. At this meeting committee will be considering a request from [...]
A diagnosis of amyloidosis can be life‑altering—not only physically, but emotionally and psychologically as well. Beyond the medical uncertainty [...]
I had the honour and privilege of attending the 2025 Amyloidosis Alliance Conference in Baveno, Italy, as a representative [...]
In 2013 I started to develop numbness and pain in my hands and in my legs from the knees [...]
The AAN is delighted to announce the appointment of a part time Telephone Support Manager, Jessica Schwendinger.This appointment is wonderful achievement made [...]
For 50 years the Leukaemia Foundation has been delivering care, driving research and supporting Australians impacted by blood cancer This organisation [...]
Pfizer funding to increase awareness about cardiac amyloidosis St Vincent’s Hospital Melbourne and the Australian Amyloidosis Network are partnering [...]
End of Financial Year Donation Appeal Over 1000 Australians are currently being treated for amyloidosis - but [...]
Amyloidosis Patient Experiences Survey (AMPES) St Vincent's Amyloid team invite all patients who have amyloidosis to take part in [...]
Both Amvuttra (vutisiran) and Onpattro (patisiran) are now listed on the PBS for treatment of hereditary ATTR amyloidosis with [...]
My name is Sean, and my Amyloidosis story began in 2011 when I started experiencing itchy skin. The doctors [...]
The AAN Facebook page forms part of the AAN’s Communications Strategy and will be used as a news and [...]